logo

Welcome Guest [Login | Register] StockFocus  •  Feedback
Google
 Check Quote

 Invest China

 Listed In US

 Misc



===================
A New Better Site for
CHINA

For Other ADRs :
BRAZIL
RUSSIA
INDIA

For Industry Group:
SOLAR ENERGY
HOME BUILDERS
CASINO

For Investing Gurus:
Warren Buffett John Paulson George Soros David Einhorn
For Real-Time Insider Trading:
Latest Buys/Sells
Buy Near 52Week Low
Buy Near 52Week High

And Much More At RealtionalStocks.com
===================


SciClone Pharmaceuticals, Inc. (NMS: SCLN)

Quote:SCLN Quotes on: Yahoo | Google
9.70
0.05 (0.51%)
Apr 25 - 4:00pm

5 day's Perf:2.51%
1 Month Perf:10.22%
3 Month Perf:3.19%
YTD Perf:5.43%
1 Year Perf:3.19%
Bid x Ask:8.55 x 9.95BidSize x AskSize:100 x 1000
Open:9.80Prev Close:9.75
Day's Range:9.65 - 9.9052wk Range:8.55 - 15.02
Volume:181630Average Vol:218831
Market Cap:499.60MEarnings:0.58
Dividend:N/ADividend Yield:N/A%
P/E ratio:16.72PEG ratio:1.06
Price/Book:2.32Price/Sale:3.14
1 yr price target:14.00Short Ratio:6.82


Quick Links for SCLN:
Financial Key Date on:YahooOption Prices on :MarketWatch
Technical Opinion:Barchar.comTechnical Charts:StockCharts.com
Earning Estimates:ReutersRatings:TheStreet.com
SEC Filings:EDGAR OnlineMessage Boards:Yahoo | TheLion

Latest Company News
SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCLN-US : October 11, 201611-Oct-16 08:16
SciClone Pharmaceuticals, Inc. ? Value Analysis (NASDAQ:SCLN) : September 29, 201629-Sep-16 10:16
SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCLN-US : September 28, 201628-Sep-16 08:16
SciClone Announces Progress In Advancing Clinical Pipeline For China Pharmaceuticals Market26-Sep-16 06:00
Soligenix (SNGX) and SciClone (SCLN) Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis12-Sep-16 11:15
Soligenix and SciClone Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis12-Sep-16 09:58
Soligenix and SciClone Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis12-Sep-16 07:00
SciClone To Present At Two Investor Conferences In September 20161-Sep-16 16:05
ETF?s with exposure to SciClone Pharmaceuticals, Inc. : August 31, 201631-Aug-16 11:49
Sciclone Pharmaceuticals Inc (SCLN) President & CEO Friedhelm Blobel Sold $5 million of Stocks18-Aug-16 23:15
SciClone posts 2Q profit9-Aug-16 17:59
SciClone posts 2Q profit9-Aug-16 17:59
SciClone Pharmaceuticals To Report Second Quarter 2016 Financial Results On August 9, 20169-Aug-16 16:30
SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements9-Aug-16 16:08
SciClone Reports Second Quarter 2016 Financial Results9-Aug-16 16:05
Q1 2017 Synutra International Inc Earnings Release - After Market Close9-Aug-16 07:07
Q2 2016 Kandi Technologies Group Inc Earnings Release - Before Market Open9-Aug-16 07:07
Q2 2016 SciClone Pharmaceuticals Inc Earnings Release - Time Not Supplied9-Aug-16 07:07
Q2 2016 Bitauto Holdings Ltd Earnings Release - Before Market Open9-Aug-16 07:07
SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits3-Aug-16 14:02
 Global Indexes
US
Dow Jones:
N/AN/A
NASDAQ:
6025.4941.67
S&P 500:
2388.6114.46
CHINA
Shanghai:
Shanghai B:
HONG KONG
Hang Seng:
24605.67149.73
H-Shares:
10336.9864.91


*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the ChinaBizFocus.com web site, a user agrees that ChinaBizFocus.com shall be not liable for any errors or delays in the content.*